Evolva reaches second milestone in Roquette collaboration
4 March 2014 – Evolva (SIX: EVE) today announces that Roquette Frères SA (Roquette) has confirmed that Evolva has achieved the second R&D milestone in their collaboration.
The ultimate objective of the collaboration is the development of novel and optimised biosynthetic production routes for an ingredient with important applications in food products. Several parameters have been defined to measure the progress of the project, including yield, productivity and production hosts. As the second major project milestone (titers and yield) has been achieved, Roquette will make a milestone payment to Evolva in the hundred thousand CHF range.
– Ends –
Evolva is a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva’s products include stevia, vanilla, saffron and resveratrol. As well as developing its own proprietary ingredients, Evolva also deploys its technology for partners, providing them with a competitive edge and sharing in the returns they make. For more information see www.evolva.com.
Roquette, a French family group with an international dimension, processes renewable raw materials: maize, wheat, potatoes, peas and microalgae. Among the 5 global leaders in the starch manufacturing industry, it offers its customers a wide range of products and solutions in the fields of human nutrition, pharmacy-cosmetology, paper-board, chemistry-bioindustry and animal nutrition. Present in over 100 countries, Roquette has a turnover of 3.1 billion euros. The group employs more than 7 800 employees. Its development, focused on nutrition and health and plant-based chemistry, is based on a strategy giving preference to the long-term, innovation and the commitment to achieve. Its mission: « Serve men and women by offering the best of nature »
|Neil Goldsmith, CEO||Jakob Dynnes Hansen, CFO||Paul Verbraeken, IR|
|[email protected]||[email protected]||[email protected]|
|+ 41 61 485 2005||+ 41 61 485 2034||+ 41 61 485 2035|
This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.
Stay informed Join our mailing list to receive Evolva’s press releases via e-mail.Join